BEMC BURLESON — History
CCN 670107 | 3-year financial timeline | COVID resilience: 36/100
🛡️ Public data only — no PHI permitted on this instance.
$31M
Latest Revenue (FY2022)
+2.1%
Revenue CAGR (3yr)
-1.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $30M | $34M | $31M | -7.8% | +2.1% |
| Operating Expenses | $26M | $29M | $31M | +9.2% | +9.4% |
| Operating Margin | 12.0% | 14.8% | -1.0% | -106.5% | +0.0% |
| Net Income | $4M | $5M | $-0M | -106.0% | +0.0% |
| Licensed Beds | 24 | 24 | 24 | +0.0% | +0.0% |
| Total Patient Days | 1,177 | 1,148 | 771 | -32.8% | -19.1% |
| Medicare Day % | 13% | 16% | 25% | +58.9% | +37.2% |
| Medicaid Day % | nan% | nan% | 1% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 36/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +4.3% ($30M → $31M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+2.1%
This Hospital
+7.6%
State Avg
Latest Margin
-1.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $32M | -7.5% |
| FY2024 (proj) | $32M | -13.9% |
| FY2025 (proj) | $33M | -20.4% |